Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome

Gynecol Endocrinol. 2018 Jan;34(1):32-35. doi: 10.1080/09513590.2017.1323204. Epub 2017 May 11.

Abstract

Aim of our study was to assess the ovulation rate, with mid-luteal progesterone level and ultrasound follicles monitoring, in PCOS CC-resistant patients undergone transvaginal hydrolaparoscopy ovarian drilling. A prospective observational study was carried out in 123 PCOS, infertile, CC-resistant patients who undergone THL ovarian drilling. Each woman was evaluated by hormonal measurement, and ultrasound evaluation during 6 months follow-up. Progesterone serum levels were assessed on days 20-24 of the cycle after surgical treatment. Pg levels >3 ng/mL were considered as ovulation. Ovulation frequency and the highest mean follicular diameters during the monitoring were recorded. 117 patients complete the study, since six patients were lost to follow-up. Mean follicular diameter during ovulation monitoring was 16.37 mm. Ovulation rate at the follow up was 64.1% one month after treatment, 79.5% after three months and 82.9% after six months. 28 patients conceived during follow-up period. Pregnancy rate was 70.1%. Our study has shown that THL ovarian drilling improves ovulation and pregnancy rate in women with CC-resistant PCOS. We believe that this approach should be offered as second-line therapy at all PCOS CC-resistant women who fail the medical methods of ovulation induction.

Keywords: Ovulation rate; polycystic ovary syndrome; progesterone levels; transvaginal hydrolaparoscopy ovarian drilling; ultrasound monitoring.

MeSH terms

  • Adult
  • Anovulation / surgery
  • Clomiphene / therapeutic use*
  • Drug Resistance
  • Female
  • Humans
  • Laparoscopy / methods*
  • Ovarian Follicle / diagnostic imaging
  • Ovary / surgery
  • Ovulation Induction / methods*
  • Ovulation* / physiology
  • Polycystic Ovary Syndrome / surgery*
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / blood
  • Prospective Studies
  • Ultrasonography

Substances

  • Clomiphene
  • Progesterone